EMA Reviews New Oral GLP-1 Drug for Diabetes and Weight Management | Retatrutide News

The EMA is reviewing a new oral GLP-1 drug for weight management and type 2 diabetes. This could impact the market and research for similar drugs, inclu...
Market News · October 16, 2026